Federated Hermes’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-65
| Closed | -$1.04K | – | 2150 |
|
|
2023
Q4 | $1.04K | Sell |
65
-5,945
| -99% | -$94.7K | ﹤0.01% | 1972 |
|
|
2023
Q3 | $458K | Sell |
6,010
-27
| -0.4% | -$2.06K | ﹤0.01% | 1367 |
|
|
2023
Q2 | $396K | Sell |
6,037
-1,802
| -23% | -$118K | ﹤0.01% | 1438 |
|
|
2023
Q1 | $469K | Sell |
7,839
-161
| -2% | -$9.63K | ﹤0.01% | 1418 |
|
|
2022
Q4 | $186K | Buy |
8,000
+5,000
| +167% | +$117K | ﹤0.01% | 1567 |
|
|
2022
Q3 | $101K | Hold |
3,000
| – | – | ﹤0.01% | 1609 |
|
|
2022
Q2 | $80K | Buy |
3,000
+1,300
| +76% | +$34.7K | ﹤0.01% | 1631 |
|
|
2022
Q1 | $50K | Hold |
1,700
| – | – | ﹤0.01% | 1739 |
|
|
2021
Q4 | $145K | Hold |
1,700
| – | – | ﹤0.01% | 1670 |
|
|
2021
Q3 | $127K | Hold |
1,700
| – | – | ﹤0.01% | 1744 |
|
|
2021
Q2 | $159K | Buy |
+1,700
| New | +$159K | ﹤0.01% | 1718 |
|